|
Lipid and lipoprotein metabolism
Citations 441-450 of 549 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Plasma Homocysteine Concentration, Statin Therapy,
and the Risk of First Acute Coronary Events
- Paul M. Ridker, Jessie Shih, Thomas J. Cook, Michael Clearfield, John R. Downs, Aruna D. Pradhan, Stephan E. Weis, Antonio M. Gotto, Jr for the Air Force/Texas
Coronary Atherosclerosis Prevention Study
(AFCAPS/TexCAPS) Investigators
Circulation published April 1, 2002, doi:10.1161/01.CIR.0000014447.06099.FB
[Abstract]
- Clinical Investigations and Reports
Peroxisome Proliferator-Activated Receptor  Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease
- David M. Flavell, Yalda Jamshidi, Emma Hawe, Inés Pineda Torra, Marja-Riitta Taskinen, M. Heikki Frick, Markku S. Nieminen, Y. Antero Kesäniemi, Amos Pasternack, Bart Staels, George Miller, Steve E. Humphries, Philippa J. Talmud, and Mikko Syvänne
Circulation 2002;105:1440-1445; published online before print as doi:10.1161/01.CIR.0000012145.80593.25
[Abstract]
[Full text]
- Clinical Investigations and Reports
Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial: To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels?
- R. John Simes, Ian C. Marschner, David Hunt, David Colquhoun, David Sullivan, Ralph A.H. Stewart, Wendy Hague, Anthony Keech, Peter Thompson, Harvey White, John Shaw, and Andrew Tonkin
Circulation 2002;105:1162-1169; published online before print as doi:10.1161/hc1002.105136
[Abstract]
[Full text]
- Correspondence
Serum Triglyceride Concentration and Coronary Heart Disease • Response
- Giuseppe Schillaci, Matteo Pirro, Elmo Mannarino, A. Richey Sharrett, Sean A. Coady, Paul D. Sorlie, Christie M. Ballantyne, Gerardo Heiss, Diane Catellier, and Wolfgang Patsch
Circulation 2002;105:e54
[Full text]
- Articles
Peroxisome Proliferator-Activated Receptor
Gene Variants Influence Progression of Coronary
Atherosclerosis and Risk of Coronary Artery
Disease
- David M. Flavell, Yalda Jamshidi, Emma Hawe, Inés Pineda Torra, Marja-Riitta Taskinen, M. Heikki Frick, Markku S. Nieminen, Y. Antero Kesäniemi, Amos Pasternack, Bart Staels, George Miller, Steve E. Humphries, Philippa J. Talmud, and Mikko Syvänne
Circulation published February 25, 2002, doi:10.1161/01.CIR.0000012145.80593.25
[Abstract]
- Articles
Relationship Between Lipid Levels and Clinical
Outcomes in the Long-Term Intervention With Pravastatin in
Ischemic Disease (LIPID) Trial. To What Extent Is the Reduction in
Coronary Events With Pravastatin Explained by
On-Study Lipid Levels?
- R. John Simes, Ian C. Marschner, David Hunt, David Colquhoun, David Sullivan, Ralph A.H. Stewart, Wendy Hague, Anthony Keech, Peter Thompson, Harvey White, John Shaw, Andrew Tonkin, and on
Behalf of the LIPID Study
Investigators
Circulation published February 18, 2002, doi:10.1161/hc1002.105136
[Abstract]
- Correspondence
Consider Cardiomyopathy in Subjects With Familial Partial Lipodystrophy • Response
- Hartmut H.-J. Schmidt and Robert A. Hegele
Circulation 2002;105:e7
[Full text]
- Brief Rapid Communications
Increased Plasma C-Reactive Protein in Familial Hypoalphalipoproteinemia: A Proinflammatory Condition?
- Tiziana Sampietro, Federico Bigazzi, Beatrice Dal Pino, Simone Fusaro, Francesco Greco, Mario Tuoni, and Alberto Bionda
Circulation 2002;105:11-14, doi:10.1161/hc0102.102847
[Abstract]
[Full text]
- Clinical Investigations and Reports
Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease
- Klaus A. Dugi, Karin Brandauer, Nikolaus Schmidt, Barbara Nau, Jochen G. Schneider, Stefani Mentz, Tanja Keiper, Juergen R. Schaefer, Christoph Meissner, Horst Kather, Malte L. Bahner, Walter Fiehn, and Joerg Kreuzer
Circulation 2001;104:3057-3062, doi:10.1161/hc5001.100795
[Abstract]
[Full text]
- Basic Science Reports
Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL
- Xiaoou Helen Xu, Prediman K. Shah, Emmanuelle Faure, Ozlem Equils, Lisa Thomas, Michael C. Fishbein, Daniel Luthringer, Xiao-Ping Xu, Tripathi B. Rajavashisth, Juliana Yano, Sanjay Kaul, and Moshe Arditi
Circulation 2001;104:3103-3108, doi:10.1161/hc5001.100631
[Abstract]
[Full text]
|
|
